| scholarly article | Q13442814 |
| P50 | author | Stephen M Lawrie | Q51761747 |
| P2860 | cites work | Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings | Q21559698 |
| Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy | Q23009758 | ||
| Maintenance treatment with antipsychotic drugs for schizophrenia | Q24197902 | ||
| Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys | Q24654374 | ||
| Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review | Q26770497 | ||
| Relapse in schizophrenia: costs, clinical outcomes and quality of life | Q39680386 | ||
| Longitudinal study of brain morphology in first episode schizophrenia | Q40718665 | ||
| Risperidone maintenance treatment in schizophrenia: a randomized, controlled trial | Q43128782 | ||
| High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: a longitudinal 31P MRS study of basal ganglia | Q43163339 | ||
| The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia | Q43201272 | ||
| Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder | Q43467235 | ||
| Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. | Q43604840 | ||
| Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients | Q43723165 | ||
| Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication | Q44676235 | ||
| Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. | Q44681644 | ||
| Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology | Q45039281 | ||
| Comparison of treatment response in second-episode versus first-episode schizophrenia | Q45043977 | ||
| Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study | Q48258798 | ||
| Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia | Q48849842 | ||
| Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia | Q50261421 | ||
| Health inequalities and the health needs of people with mental illness. | Q51952060 | ||
| Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. | Q55053712 | ||
| Schizophrenia | Q55868331 | ||
| Longitudinal Volume Reductions in People at High Genetic Risk of Schizophrenia as They Develop Psychosis | Q57316778 | ||
| Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine | Q57834282 | ||
| Schizophrenia | Q71574804 | ||
| Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment | Q73008054 | ||
| Psychotic relapse and maintenance therapy in paranoid schizophrenia: a 15 year follow up | Q77882915 | ||
| Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses | Q26853468 | ||
| A systematic review and meta-analysis of recovery in schizophrenia | Q26859162 | ||
| Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies | Q26865740 | ||
| Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research | Q28082090 | ||
| Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis | Q28266069 | ||
| Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study | Q30156623 | ||
| Neurocircuitry in alcoholism: a substrate of disruption and repair | Q30987336 | ||
| Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia | Q30992898 | ||
| Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies | Q32082435 | ||
| Compounded brain volume deficits in schizophrenia-alcoholism comorbidity | Q33186290 | ||
| Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? | Q33762467 | ||
| Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 | ||
| Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies | Q33860665 | ||
| Meta-analysis of regional brain volumes in schizophrenia | Q33885349 | ||
| The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys | Q33985626 | ||
| 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). | Q34018491 | ||
| Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study | Q34051101 | ||
| Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies | Q34282907 | ||
| Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. | Q34337272 | ||
| Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. | Q34351095 | ||
| Antipsychotic drug effects on brain morphology in first-episode psychosis | Q34408860 | ||
| The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies | Q34468314 | ||
| Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys | Q34576434 | ||
| The impact of substance use on brain structure in people at high risk of developing schizophrenia | Q35177137 | ||
| Towards consensus in the long-term management of relapse prevention in schizophrenia | Q36031050 | ||
| Different outcomes of never-treated and treated patients with schizophrenia: 14-year follow-up study in rural China | Q36333267 | ||
| A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. | Q36692829 | ||
| Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects | Q37131066 | ||
| Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies | Q37236148 | ||
| Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia | Q38371590 | ||
| Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis | Q38942045 | ||
| Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study | Q39048817 | ||
| Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis | Q39233778 | ||
| Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. | Q39328454 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 319-326 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Therapeutic advances in psychopharmacology | Q26842244 |
| P1476 | title | Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective | |
| P478 | volume | 8 |
| Q90050151 | What Would Digital Early Intervention for Bipolar Disorder Look Like? Theoretical and Translational Considerations for Future Therapies | cites work | P2860 |
Search more.